Quinn Everts

A look at how the genetics-based research field can become more fully integrated in all areas of health care going forward.

A research article outlines the future of artificial intelligence in health care.

Data presented at Digestive Disease Week show that patients with IBD had less intense post-vaccination symptoms after a fourth dose.

Keeping inventory in pharmacy is already difficult. And keeping stock of dangerous substances like opioids requires even more caution.

The drug is a rare FDA-approved liquid formulation that treats ulcers and lowers risk of gastrointestinal bleeding in chronically ill patients.

An increased dose of the diabetes treatment semaglutide caused significant improvement in blood sugar levels and body weight for patients with type 2 diabetes (T2D), according to study results.1 The phase 3 trial PIONEER PLUS was conducted over the span of 68 weeks and included more than 10,000 patients with T2D. “The trial achieved its primary endpoint by demonstrating a statistically significant and superior reduction in HbA1c [hemoglobin A1C] at week 52 with both the 25 mg and 50 mg doses ve…

The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.

The British pharma giant has teamed up with Johnson for a promotional campaign as they approach the finish line of an RSV vaccine.

The product, called Lenire, uses bimodal stimulation and will be available in April 2023

The President said he will make Medicare “solvent beyond 2050 without cutting a penny in benefits.”

Your weekly roundup of the latest news from Drug Topics®.

The pharmaceutical giant announced a 70% price reduction for most of its commonly sold insulin.

Pharmacists generally agree that domestic production of the commonly used antibiotic could prevent more shortages from happening in the future

The vaccine would be administered to pregnant people to protect newborns from RSV.